Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study.

Myunhee LeeYu Ah HongJun-Pyo MyongKyusup LeeMahn-Won ParkDae-Won Kim

Published in: PloS one (2023)

The prevalence of statin prescriptions in dialysis patients after ASCVD event increased from 2013 to 2018. Most patients received moderate-intensity statin. However, high-intensity statin and statin/ezetimibe combination therapy has remarkably increased. Statin use was associated with decreased 1-year all-cause mortality in dialysis patients with ASCVD.

Keyphrases

end stage renal disease
cardiovascular disease
chronic kidney disease
high intensity
peritoneal dialysis
coronary artery disease
newly diagnosed
ejection fraction
combination therapy
stem cells
low density lipoprotein
risk factors
resistance training
body composition
metabolic syndrome
patient reported